Search Results 261-270 of 16553 for ������������KA���:ZA31���24������ ���������������������������������

  1. Aspiration for Pain Relief Following Ankle Fracture - Mayo Clinic

    Injury within 24 hours of presentation; Skeletally mature; Able to provide consent to participate in study. Exclusion Criteria: Any concomitant injuries ...

  2. A Study to Evaluate S-600918 in Adults With Refractory Chronic Cough - Mayo Clinic

    ... 24-hour cough frequency (coughs per hour) with S-600918 compared with placebo. Participation eligibility. Participant eligibility includes age, gender, type ...

  3. Study To Assess Adverse Events And Change In Disease Activity In Previously Treated Adult Participants Receiving Intravenous (IV) ABBV-400 With Unresectable Metastatic Colorectal Cancer In Combination With IV Fluorouracil, Folinic Acid, And Bevacizumab - Mayo Clinic

    Scottsdale/Phoenix, Arizona: 24-006223; Jacksonville, Florida: 24-006223. NCT ID: NCT06107413. Sponsor Protocol Number: M24-311. About this study. The purpose ...

  4. https://www.mayoclinic.org/chinese_organization_concepts.xml

    ... 24-05:00</lastmod><xhtml:link rel="alternate" hreflang="ar" href="https://www.mayoclinic.org/ar/departments-centers/cardiovascular-medicine/sections ...

  5. A Study of Momelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Patients - Mayo Clinic

    Subjects randomized to receive DAN who are receiving clinical benefit at the end of Week 24 may choose to continue DAN therapy up to Week 48. The comparator ...

  6. Publications - Vlad C. Vasile, M.D., Ph.D. - Mayo Clinic

    2017 Aug 24; 19 (10):92. View PubMed; Vasile VC, Jaffe AS. Natriuretic Peptides and Analytical Barriers. Clin Chem. 2017 Jan; 63 (1):50-58 Epub 2016 Oct 10

  7. A Study of MT-0169 in Participants With Relapsed or Refractory Multiple Myeloma or non-Hodgkin Lymphoma - Mayo Clinic

    Urine M-protein ≥ 200 mg/24 h on urine protein electrophoresis (UPEP). Serum FLC assay result with an involved FLC level ≥ 10 mg/dL (≥ 100 milligram per ...

  8. Cancer Treatment! Clinical Trials - Mayo Clinic Research

    ... 24 than treatment with Best Available Therapy, and a greater proportion of patients achieving a ≥ 50% reduction in total symptom score from baseline to ...

  9. SAR650984, Pomalidomide and Dexamethasone in Combination in RRMM Patients - Mayo Clinic

    - To assess the relationship between clinical effects (adverse event [AE] and/or tumor response) and CD38 receptor density at baseline (Part A). Participation ...

  10. Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis - Mayo Clinic

    About this study. The purpose of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm ...